Camber Capital Management as of Dec. 31, 2010
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 38 positions in its portfolio as reported in the December 2010 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Community Health Systems (CYH) | 6.4 | $39M | 1.1M | 37.37 | |
| CareFusion Corporation | 6.1 | $37M | 1.5M | 25.70 | |
| Humana (HUM) | 6.0 | $37M | 676k | 54.74 | |
| UnitedHealth (UNH) | 5.9 | $36M | 1.0M | 36.11 | |
| Walgreen Company | 5.7 | $35M | 900k | 38.96 | |
| Boston Scientific Corporation (BSX) | 4.9 | $30M | 4.0M | 7.57 | |
| Zimmer Holdings (ZBH) | 4.8 | $30M | 550k | 53.68 | |
| CVS Caremark Corporation (CVS) | 4.5 | $28M | 800k | 34.77 | |
| Regeneron Pharmaceuticals (REGN) | 3.9 | $24M | 730k | 32.83 | |
| Tenet Healthcare Corporation | 3.8 | $23M | 3.5M | 6.69 | |
| Elan Corporation | 3.7 | $23M | 4.0M | 5.73 | |
| LifePoint Hospitals | 3.7 | $23M | 622k | 36.75 | |
| Conceptus | 3.4 | $21M | 1.5M | 13.80 | |
| NuVasive | 3.3 | $20M | 793k | 25.65 | |
| Health Management Associates | 3.1 | $19M | 2.0M | 9.54 | |
| Acorda Therapeutics | 2.7 | $16M | 601k | 27.26 | |
| ArthroCare Corporation | 2.5 | $16M | 502k | 31.06 | |
| WellCare Health Plans | 2.4 | $15M | 494k | 30.22 | |
| Auxilium Pharmaceuticals | 2.4 | $15M | 687k | 21.10 | |
| AngioDynamics (ANGO) | 2.3 | $14M | 914k | 15.37 | |
| Wright Medical | 2.2 | $14M | 877k | 15.53 | |
| Universal American Corporation | 2.1 | $13M | 623k | 20.45 | |
| Targacept | 2.0 | $12M | 464k | 26.50 | |
| St. Jude Medical | 1.7 | $11M | 250k | 42.75 | |
| SonoSite | 1.7 | $10M | 325k | 31.60 | |
| Dynavax Technologies Corporation | 1.5 | $9.3M | 2.9M | 3.20 | |
| Lorillard | 1.3 | $8.2M | 100k | 82.06 | |
| Cardionet | 1.3 | $8.1M | 1.7M | 4.68 | |
| AMAG Pharmaceuticals | 0.9 | $5.4M | 300k | 18.10 | |
| Rite Aid Corporation | 0.8 | $4.9M | 5.6M | 0.88 | |
| WorldHeart Corporation (WHRT) | 0.6 | $3.7M | 1.6M | 2.27 | |
| Dynavax Technologies Corporation | 0.5 | $3.2M | 1.7M | 1.84 | |
| Celgene Corp right 12/31/2011 | 0.5 | $3.2M | 649k | 4.90 | |
| Omnicell (OMCL) | 0.5 | $3.0M | 208k | 14.45 | |
| Somaxon Pharmaceuticals | 0.3 | $1.6M | 500k | 3.15 | |
| Anthera Pharmaceuticals | 0.2 | $964k | 400k | 2.41 | |
| WorldHeart Corporation (WHRT) | 0.2 | $984k | 1.6M | 0.60 | |
| ViroPharma Incorporated | 0.0 | $32M | 1.9M | 16.61 |
